Please login to the form below

Not currently logged in
Email:
Password:

S-A wins award for malaria programme

Sanofi-aventis has won the 2010 Global Business Coalition Core Competence Award for its Malaria Access to Medicines programme

Sanofi-aventis (S-A) has won the 2010 Global Business Coalition Core Competence Award for the Malaria Access to Medicines programme – a campaign to combat the disease, devised in partnership with the Drugs for Neglected Diseases Initiative (DNDi).

The awards honour organisations who have shown pioneering skills and strategies in the fight against HIV/AIDS, tuberculosis and malaria.

Previous winners have included Warner Bros. Entertainment, who developed an action-based video game pilot that delivered targeted HIV prevention messages to East African youths, and the BBC World Service Trust for its mass media HIV/AIDS campaign in India.

The Malaria Access to Medicines Programme has seen S-A and not-for-profit product developers, DNDi, develop and distribute anti-malarial treatment, Coarsucam, or ASAQ (artesunate amodiaquine winthrop) in the poorest areas of sub-sharan Africa.

ASAQ is the first anti-malarial treatment to be aimed at such a patient group, in particular children.

The treatment costs less than $1 for an adult and less than $0.50 for children when distributed to non-profit organisations in the area.

More than 50 million ASAQ treatments have been distributed since 2008 when the treatment was pre-qualified by the World Health Organisation (WHO).

Commenting on the award, Global Business Coalition CEO, John Todstrom said: "The sanofi-aventis ASAQ programme has produced real results in helping to address one of the three greatest threats of our time. We congratulate them on their richly deserved success."

25th May 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics